386880006: Zafirlukast (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Leukotriene receptor antagonist\Zafirlukast (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Leukotriene receptor antagonist\Zafirlukast (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461058012 Zafirlukast (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1480994011 Zafirlukast en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

375501000195110 zafirlukast it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

850081000172114 zafirlukast fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zafirlukast (substance)	Is a	Leukotriene receptor antagonist	true	Inferred relationship	Some
Zafirlukast (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Leukotriene receptor antagonist (disposition)	true	Inferred relationship	Some
Zafirlukast (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing zafirlukast (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zafirlukast (substance)	Inferred relationship	Some
Zafirlukast 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zafirlukast (substance)	Inferred relationship	Some
Zafirlukast 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zafirlukast (substance)	Inferred relationship	Some	1
Product containing zafirlukast in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zafirlukast (substance)	Inferred relationship	Some	1
Zafirlukast only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zafirlukast (substance)	Inferred relationship	Some	1
Product containing only zafirlukast in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zafirlukast (substance)	Inferred relationship	Some	1

This concept is not in any reference sets